// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Delta 12s index as a screening tool for obstructive sleep apnoea in children

Antonia McBride - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Down syndrome

N/A

National survey of physiotherapy and speech & language therapists’ practice for patients with chronic cough in England: patient care optimisation

Jemma Haines - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Breathlessness in primary care-prevalence and physiotherapy management of breathing pattern disorders

Ruth De Vos - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Prevalence of inducible laryngeal obstruction with breathing pattern disorders and the outcomes of physiotherapy management

Ruth De Vos - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD)

Enya Daynes - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Sulfur hexafluoride

The impact of breathing therapy in those with difficult asthma

Leyla Osman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A national audit of the Aerobika* Oscillatory Positive Pressure (OPEP) device when used to assist airway clearance for those with cystic fibrosis, bronchiectasis and COPD

Amanda Bracey - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Cystic Fibrosis

N/A

National survey of physiotherapy and speech and language therapists’ practice for patients with chronic cough in England: Assessment

Sarah Chamberlain Mitchell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

National survey of physiotherapy and speech and language therapists’ practice for patients with refractory chronic cough in England: Treatment

Sarah Chamberlain Mitchell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A rapid response community respiratory service for children with complex needs reduces hospital admissions

Leanne Turner - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Families perception of a rapid response community respiratory physiotherapy team

Leanne Turner - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of a multidisciplinary clinic on children with complex breathlessness

Claire Hepworth - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field

Chris Burtin - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Breath Holding Time in uncontrolled Asthma: associations with key physiological tests and patient-reported outcome measures

Karen Hjerrild Andreasson - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Rasch validation of the Asthma Control Questionnaire

Karen Hjerrild Andreasson - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Energy expenditure and cardiovascular responses to a new Spot Marching Exercise test

Chatchai Phimphasak - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Frailty in chronic respiratory disease: prevalence and comparison of rehabilitation clinical outcomes

Ken Johnston - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary arterial hypertension

N/A

Physical activity trajectories and their determinants in COPD: A cohort study

Maria Koreny - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The association of comorbid pain with incident falls in people with chronic obstructive pulmonary disease

Kirsti J Loughran - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Meeting the National Mesothelioma Audit standards in clinical practice: How achievable is it?

Elizabeth Romer - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Copyright © 2026. QuantiNova All rights reserved